IL165223A0IL16522303AIL16522303AIL165223A0IL 165223 A0IL165223 A0IL 165223A0IL 16522303 AIL16522303 AIL 16522303AIL 16522303 AIL16522303 AIL 16522303AIL 165223 A0IL165223 A0IL 165223A0
Authority
IL
Israel
Prior art keywords
receptor modulators
nuclear receptor
steroid hormone
hormone nuclear
tricyclic steroid
Prior art date
Application number
IL16522303A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Priority claimed from PCT/US2003/016213external-prioritypatent/WO2004052847A2/en
Publication of IL165223A0publicationCriticalpatent/IL165223A0/en